Implementing Effective Clinical Protocols to Reduce Diagnostic and Treatment Delays in Patients with

Fibrosing ILDs

Congratulations!

You’ve taken the first step for you and your practice to achieve measurable changes that will ensure your infrastructure and processes are optimized to support treatment, therapy selection, and care coordination for diverse patients with metastatic castration-resistant prostate cancer (mCRPC).

Using this simple, systematic approach to quality improvement, intended for easy access and application in any practice setting, you will have the framework and tools you need to improve guideline-recommended screening and management practices. Let’s get started!

Participate in digital QI

This digital QI is designed to be effective and as easy as 1-2-3

1

Assess

To assess possible areas of improvement, you will complete an assessment that asks to what extent you or your practice:

  • ensures that somatic and germline testing have previously been performed (or re-evaluated, if needed)
  • improves clinical trial access for racially and ethnically diverse patients
  • ensures that patients with mCRPC receive personalized treatment
  • develops processes to ensure equitable access to advanced imaging techniques
  • establishes processes to ensure that patients with mCRPC receive all components of supportive care
  • ensures that the multidisciplinary team is familiar with racial disparities in treatment access
  • addresses social determinants of health that influence patient access to treatment

You will receive a report card that summarizes your or your practice’s performance relative to areas assessed. This serves as your baseline and guides development of your personalized action items.

2

Implement in Practice

Working with our expert faculty, we followed a Model for Improvement that outlines the aims of this program and its measures of success. We provide educational and practical interventions, but you can develop your own to meet your specific needs. Depending on your baseline assessment, interventions you can implement include:

  • Enhanced training
  • Communication strategies
  • Personalized action items to track based on the nuanced needs of your practice
  • Team-based approaches to address disparities
  • Patient education
3

Re-assess

Once you’ve finished the interventions and have introduced the recommended process changes, it’s time to put them to the test!

  • Return to this digital QI portal after a minimum of
  • Re-assess your action plan to see what improvements were realized
  • Complete a personal reflection
  • Get your certificate

We recommend you share these findings with key stakeholders in your organization to reflect on ongoing improvements and/or future opportunities.

Obtain MOC Part IV Credit for You and Your Team

Faculty

Russell Z. Szmulewitz, MD (Chair) Professor of Medicine
Director, Genitourinary Oncology Program
Associate Director for Clinical Investigation, Comprehensive Cancer Center
Co-Director, High Risk and Advanced Prostate Cancer Clinic
University of Chicago
Chicago, IL
Samuel L. Washington III, MD, MAS (Faculty) Assistant Professor, Urology
Urologic Oncologist
University of California, San Francisco
San Francisco, CA
Meghan Catenacci, BSN, RN, MS (Faculty) Oncology Nurse Navigator
Hematology/Oncology
University of Chicago Medicine
Chicago, IL
Timothy McNichol, LCSW (Faculty) Genitourinary Outpatient Social Worker
Medical Oncology
University of Chicago Medicine
Chicago, IL
Rebecca LaRue, PharmD, BCOP (Pharmacy Planner) Clinical Pharmacy Specialist Hematology/Oncology/Cellular Therapy
Team Lead Hematology/Oncology Pharmacy
Rush University Medical Center
Chicago, IL

Not interested in participating in this digital QI but want to view our tools and resources?

Access the Toolkit